Timely consultations relevant for family medicine, primary care, and general internal medicine topics for physicians, nurse practitioners, physician assistants, and residents. Offering CME credit for most episodes at https://ce.mayo.edu/podcast. Produced by @MayoMedEd.
Episodes
Friday Mar 19, 2021
Friday Mar 19, 2021
This episode is shared from Mayo Clinic Q&A and was recorded in March 2021.
Guest: Gregory A. Poland, M.D. (@drgregpoland)
Host: DeeDee Stiepan (@deedeestiepan)
Millions of people in the U.S. are being vaccinated for COVID-19. However, discussion is ongoing as to whether people who are immunocompromised, such as patients undergoing cancer treatment, or people who have autoimmune diseases, should be vaccinated for COVID-19.
"Both of those categories (of people) should be vaccinated," says Dr. Gregory Poland, an infectious diseases expert and head of Mayo Clinic's Vaccine Research Group. "Those are not contraindications. Those are indications to get the vaccine." He adds that research is ongoing, but current information demonstrates the benefits far outweigh the theoretical risks.
In this Mayo Clinic Q&A podcast, Dr. Poland talks about vaccine hesitancy, and patients who are immunocompromised or have autoimmune conditions. Also, he discusses next steps in the journey to vaccinate children for COVID-19. And he reviews recent guidance from the Centers for Disease Control and Prevention Control about in-person gatherings.
AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.
Thursday Mar 18, 2021
Thursday Mar 18, 2021
* WARNING: This episode discusses suicide and suicidal ideation. *
Guest: J. Michael Bostwick, M.D.(@DrBostwick)
Host: Amit K. Ghosh, M.D. (@AmitGhosh006)
In this episode, professor of psychiatry and international authority on suicide risk and challenges in suicide prevention, J. Michael Bostwick, M.D. from Mayo Clinic in Rochester joins us. He’ll discuss epidemiological-based research looking at the utilization patterns of medical care by individuals who have contemplated or committed suicide. Dr. Bostwick will describe the concept of suicide crisis including risk factors, current events/warning signs, and mental status/agitation. He’ll also explain self-agency, stigma of discussing mental illness, potential value-based societal approach to individuals in distress and despair, and potential solutions to the suicide prevention.
Additional resources:
- Suicide Prevention in Primary Care Medicine; Huguet, Nathalie et al.; Mayo Clinic Proceedings, Volume 90, Issue 11, 1459 – 1461; https://doi.org/10.1016/j.mayocp.2015.09.011
- Grappling With Suicide Risk; Sublette, M. Elizabeth; Mayo Clinic Proceedings, Volume 93, Issue 6, 682 – 683; https://doi.org/10.1016/j.mayocp.2018.04.006
- Suicide Attempt as a Risk Factor for Completed Suicide: Even More Lethal Than We Knew; Bostwick, J. Michael et al.; Amer Journal of Psychiatry; Volume 173, Issue 11, November 01, 2016, 1094-1100; https://doi.org/10.1176/appi.ajp.2016.15070854
If you're feeling overwhelmed by thoughts of not wanting to live or you're having urges to attempt suicide, get help now.
- Call 911 or your local emergency number immediately.
- Call a suicide hotline. In the U.S., call the National Suicide Prevention Lifeline at 1-800-273-8255 any time of day — press "1" to reach the Veterans Crisis Line or use Lifeline Chat.
- For a list of suicide hotline numbers outside of the U.S., visit: https://www.opencounseling.com/suicide-hotlines
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.
Wednesday Mar 17, 2021
Wednesday Mar 17, 2021
This episode is shared from Mayo Clinic Q&A and was recorded in March, 2021.
Guest: Billie A. Schultz, M.D.
Host: Halena M. Gazelka, M.D. (@hmgazelkamd)
Fatigue and what's being called "brain fog" are turning out to be some of the most common issues for long-hauler patients recovering from COVID-19. The National Institutes of Health calls these and other symptoms, which can last for several months, post-acute sequelae of SARS-CoV-2, or PASC.
Those suffering from brain fog may experience short-term memory loss, confusion, difficulty concentrating, or just feeling different than they did before they had COVID-19, even if it was a mild case of the infection.
And Dr. Billie Schultz, a Mayo Clinic physical medicine and rehabilitation expert, says, though older patients more often to have these symptoms more often, younger people are also showing up with brain fog.
In this Mayo Clinic Q&A podcast, Dr. Schultz says brain fog seems to be more inflammatory than infection, but there are more questions than answers about this neurological concern. Meanwhile, efforts are underway to develop rehabilitation programs to help patients recover.
AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.
Tuesday Mar 16, 2021
Tuesday Mar 16, 2021
Guest: Ravindra Ganesh, M.B.B.S., M.D.
Host: Amit K. Ghosh, M.D. (@AmitGhosh006)
It has been estimated that as many as 10-30% of patients who have recovered from COVID-19 have an array of symptoms, ranging from minor to disabling, that persist more than four weeks post-COVID infection. These symptoms have not only been identified in patients who had severe symptoms of COVID-19 requiring intensive care unit treatment, but also those who only experienced mild-to-moderate symptoms.
The exact cause of this state, most popularly called post-COVID long hauler syndrome, is still under investigation. The symptoms range from mild to disabling fatigue, body aches, atypical chest pain, loss of sense of taste and smell, brain fog, among others and many of these patients need additional evaluation and management to deal with their disabling symptoms.
In this podcast Dr. Ravindra Ganesh, the consultant in General Internal Medicine who leads the COVID Frontline Care Team (CFCT) efforts, as well as the Post-COVID Clinic, at Mayo Clinic Rochester, discusses the array of symptoms, management strategies, and research possibilities, as well as opening of an upcoming clinic in Mayo Clinic Rochester that would address the concern of the patient's and deal with the post COVID long hauler symptoms
Additional Resources:
- Post-COVID Syndrome on Ask Mayo Expert: https://askmayoexpert.mayoclinic.org/
- To refer a patient to or request an appointment at Mayo Clinic, visit: https://www.mayoclinic.org/appointments
- Post-COVID Recovery on Mayo Clinic Connect: https://connect.mayoclinic.org/page/post-covid-recovery/
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.
Tuesday Mar 09, 2021
Tuesday Mar 09, 2021
Guest: Maria I. Vazquez Roque, M.D. (@MVazquezRoqueMD)
Host: Darryl S. Chutka, M.D. (@ChutkaMD)
Clostridium difficile is a toxin-producing bacterium that can result in a severe form of antibiotic-associated diarrhea known as clostridium difficile infection or CDI. Cases can vary from mild diarrhea to severe colitis that at times can be fatal. There’s been a dramatic increase in the number as well as severity of CDIs in the U.S. over the past 20 years. Although CDI typically occurs following the use of antibiotics, it can also be spread from one individual to another, especially in hospitals and skilled nursing facilities. Antibiotics have been the traditional treatment for patients with CDI, however recurrent symptoms have been a problem. There’s now a new treatment for CDI, felt to be effective in over 90% of patients with the illness. Our guest to discuss this topic is Dr. Maria Vazquez Roque, a gastroenterologist at the Mayo Clinic. We’ll review the common presenting symptoms, laboratory tests needed to establish a diagnosis, and the current recommendations for treatment including the latest of fecal transplantation.
Additional resources:
Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA): https://doi.org/10.1093/cid/cix1085
Specific topics discussed:
- The typical presentation of C. difficile infection
- Patients who are at increased risk for a C. difficile infection
- Laboratory tests to order to confirm a case of C. difficile infection
- Treatment options for C. difficile infection including fecal transplantation
- Potential benefit of probiotics for preventing a C. difficile infection
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.
Wednesday Mar 03, 2021
Wednesday Mar 03, 2021
This episode is shared from Mayo Clinic Q&A and was recorded in February, 2021
Guest: Gregory A. Poland, M.D. (@drgregpoland)
Host: Halena M. Gazelka, M.D. (@hmgazelkamd)
People may be curious, confused or critical of what seem to be changing messages related to the COVID-19 pandemic.
Dr. Gregory Poland, an infectious diseases expert and head of Mayo Clinic's Vaccine Research Group, reminds folks that messages change because data changes and the science evolves.
"As we learn new science, we use that science to modify our recommendations," says Dr. Poland. "It's not that scientists are flip-flopping. It is that new data allows us to begin expanding those recommendations."
For instance, COVID-19 cases and deaths in the U.S. are currently declining. But, Dr. Poland says, there are new data predicting the possibility of another surge of COVID-19 infections in March because of U.K. variant transmission.
In this Mayo Clinic Q&A podcast Dr. Poland talks about several issues, including the U.K. variant, vaccine development and the public’s COVID-19 fatigue.
AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.
Tuesday Mar 02, 2021
Tuesday Mar 02, 2021
Guest: Ravindra Ganesh, M.B.B.S., M.D. and Raymund R. Razonable, M.D.
Host: Amit K. Ghosh, M.D. (@AmitGhosh006)
In this episode, Ravindra Ganesh, M.B.B.S., M.D. and Raymund R. Razonable, M.D. join Amit K. Ghosh, M.D. to review the use of monoclonal antibody as a new antiviral agent in the treatment of COVID-19 infection.
Who is most likely to benefit from monoclonal antibody infusions? Drs. Ganesh and Razonable, discuss recent studies on monoclonal antibody infusions in patients with mild to moderate COVID-19 infections. Also discussed are the logistical challenges faced and the innovative solutions that were implemented while administering this therapy, particularly navigating the acceptance of treatment, its real and perceived side effects, and lack of awareness due to inequity and poverty. Research on the development of subcutaneous or intramuscular administration for prophylaxis against COVID-19 in patients at high risk for complications or at high risk for being exposed to SARS-CoV-2 is also discussed in this episode.
Additional resources:
- AskMayoExpert COVID-19 Navigator: https://askmayoexpert.mayoclinic.org/navigator/COVID-19
- Weinreich DM, Sivapalasingam S, Norton T, et al. REGN-COV2, a neutralizing antibody cocktail, in outpatients with Covid-19. N Engl J Med 2021;384:238-251.
- Chen P, Nirula A, Heller B, et al. SARS-CoV-2 neutralizing antibody LY-CoV555 in outpatients with Covid-19. N Engl J Med 2021;384:229-237.
- Gottlieb RL, Nirula A, Chen P, et al. Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19: A Randomized Clinical Trial.JAMA. Published online January 21, 2021. doi:10.1001/jama.2021.0202
- An EUA for Bamlanivimab—A Monoclonal Antibody for COVID-19. JAMA. Published online December 11, 2020. doi:10.1001/jama.2020.24415
- Monoclonal Antibodies: Update on this COVID-19 Experimental Therapy https://discoverysedge.mayo.edu/2021/02/17/monoclonal-antibodies-update-on-this-covid-19-experimental-therapy/
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.
Tuesday Feb 16, 2021
Tuesday Feb 16, 2021
Guest: Greg Vanichkachorn, M.D., M.P.H.
Host: Amit K. Ghosh, M.D. (@AmitGhosh006)
For some patients who have had COVID-19, symptoms of the disease may last long after the infection is over. Long-haulers syndrome due to COVID-19 could include profound fatigue, shortness of breath, and long-term neurological complaints, including headache, dizziness, or weakness. Mayo Clinic has launched the COVID Activity Rehabilitation Program, or CARP, to help these patients return to daily life and work. CARP is not just for folks who are trying to get back to work, but for anyone trying to get back to their baseline life.
In this episode, Dr. Greg Vanichkachorn, a Mayo Clinic preventive, occupational and aerospace medicine specialist who leads the CARP program, gives an overview of COVID long haulers and how post-COVID symptoms affects patients. He also shares the goals and results of Mayo Clinic CARP program.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.
Tuesday Feb 09, 2021
Tuesday Feb 09, 2021
This episode is shared from Answers from the Lab and was originally published February 2, 2021.
Guest: Matthew J. Binnicker, Ph.D. (@DrMattBinnicker)
Host: William G. Morice, II M.D., Ph.D. (@moricemdphd)
Matthew Binnicker, Ph.D., vice chair of practice for Mayo Clinic's Department of Laboratory Medicine and Pathology, joins William Morice II, M.D., Ph.D., president of Mayo Clinic Laboratories, for this week's "Answers From the Lab" leadership update. In this episode, Dr. Binnicker and Dr. Morice discuss the impact that emerging COVID-19 variants could have on virus testing, vaccine and spread.
For more, follow the Mayo Clinic Labs on Twitter @mayocliniclabs or visit https://news.mayocliniclabs.com/podcast/answers-from-the-lab/ to check out all of their episodes.
Tuesday Feb 09, 2021
Tuesday Feb 09, 2021
Guest: Ravindra Ganesh, M.B.B.S., M.D.
Host: Amit K. Ghosh, M.D. (@AmitGhosh006)
The Mayo Clinic COVID Frontline Healthcare Team (CFCT) is an integrated team comprised of doctors and support staff, including nurses, remote monitoring technicians, medical assistants, and desk staff. These teams are responsible for evidence-based management of all newly diagnosed COVID-19 patients. We’re joined by CFCT Codirector Ravindra Ganesh, M.B.B.S., M.D., to discuss the essential roles of CFCT’s during the pandemic.
Topics include how they:
- Notify all patients who receive a COVID positive test result in Mayo/Mayo Clinic Health service in the Midwest region through phone call or portal messaging with attached questionnaire
- Conduct outpatient monitoring and follow-up as well as identify patient at high risk for decompensation
- Prevent COVID positive patients from coming to the Mayo Clinic facilities by remote monitoring and risk assessment
- Reinforce social isolation recommendations from public health to all COVID positive patients and assess safety to come off isolation
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.
Monday Feb 08, 2021
Monday Feb 08, 2021
This episode is shared from Mayo Clinic Q&A and was recorded in February, 2021
To claim credit visit: https://ce.mayo.edu/covid19podcast
Guest: David B. Soma, M.D. (@DrDaveSoma); Talha Niaz, M.B.B.S.
Host: Angela C. Mattke, M.D. (@DrAngelaMattke)
There are many benefits to sports participation for children and adolescents. However, during the COVID-19 pandemic, activities such as youth sports have been put on hold or modified to decrease the spread of COVID-19. Also, the scientific community is learning about when it is safe to return to sports participation following COVID-19 infection.
On the Mayo Clinic Q&A podcast, "Ask the Mayo Mom" host and Mayo Clinic pediatrician, Dr. Angela Mattke is joined by Dr. David Soma, a pediatric sports medicine physician at Mayo Clinic Children's Center, to discuss sports participation during the COVID-19 pandemic and what you need to know about return to play after COVID-19 infection. Also joining Drs. Mattke and Soma is Dr. Talha Niaz, a pediatric cardiologist at Mayo Clinic.
AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.
Thursday Feb 04, 2021
Thursday Feb 04, 2021
This episode is shared from Mayo Clinic Q&A and was recorded in February, 2021
To claim credit visit: https://ce.mayo.edu/covid19podcast
Guest: Gregory A. Poland, M.D. (@DrGregPoland)
Host: Halena M. Gazelka, M.D. (@hmgazelkamd)
When it comes to the COVID-19 pandemic, Dr. Gregory Poland, an infectious diseases expert and head of Mayo Clinic's Vaccine Research Group, says there's some good news. "Case numbers are falling, masking and distancing do work, and we can control this if we do it right."
However, the not so good news is that variants are showing up in over 30 countries and are reportedly more transmissible. There also seems to be a reduction in vaccine efficacy against the new variants.
"This is a desperate race between vaccine and virus, between time and opportunity, and we dare not lose that opportunity," emphasizes Dr. Poland.
In this Mayo Clinic Q&A podcast, Dr. Poland discusses how COVID-19 viruses mutate into new variants. He also discusses recent COVID-19 research conducted by the NFL, plus he touches on the future of individualized vaccines. "I can see the development of a coronavirus vaccine against multiple types of coronavirus, including the one that causes the common cold, and very likely combine that with the influenza vaccine."
AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.
Thursday Feb 04, 2021
Thursday Feb 04, 2021
This episode is shared from Mayo Clinic Q&A and was recorded in January, 2021.
To claim credit visit: https://ce.mayo.edu/covid19podcast
Guest: Gregory A. Poland, M.D. (@drgregpoland)
Host: Halena M. Gazelka, M.D. (@hmgazelkamd)
The distribution kinks for COVID-19 vaccines are getting ironed out, says Dr. Gregory Poland, an infectious diseases expert and head of Mayo Clinic's Vaccine Research Group.
"It's a logistics nightmare, but now you're seeing a plan to administer 1 million doses a day and I think that's very achievable," says Dr. Poland. "And the production of the vaccine is just going to accelerate."
Dr. Poland also repeats the reminders about preventing transmission of COVID-19:
- Wear a mask.
- Wash your hands.
- Keep your social distance.
"The current estimates are that in the next four weeks, we'll probably have about another 100,000 deaths," adds Dr. Poland. "It's stunning when you think about 1 out of every 860 Americans has now died of this."
In this Mayo Clinic Q&A podcast, Dr. Poland talks more about the rollout, transmission and herd immunity, as well as fertility issues related to COVID-19, survivor brain fog and more.
AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.
Tuesday Feb 02, 2021
Tuesday Feb 02, 2021
Guest: Patricio Gargollo, M.D. (@pgargollo)
Host: Darryl S. Chutka, M.D. (@ChutkaMD)
Enuresis is relatively common in children, estimated to be present in as many as 5 to 10% of 7-year-olds. This represents up to 7 million children in the United States. As you can imagine, it carries significant social implications for the child. Our guest for this podcast is Dr. Patricio Gargollo, a pediatric urologist at Mayo Clinic in Rochester, Minnesota. Dr. Gargollo will address the natural history of enuresis, how to evaluate the child with enuresis, how often it represents a structural urologic problem and how often a treatable cause is found. Practical advice for parents of children with enuresis is also discussed.
Specific topics:
- Potential for children with enuresis to have bladder control problems when they develop into adulthood.
- Social impact of enuresis on a child.
- Potential risk factors and causes of enuresis.
- The role of genetics and enuresis.
- The natural history of enuresis.
- How often a structural urologic problem is found to explain enuresis.
- Pharmacologic treatment options.
- The evaluation of a child with enuresis.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.
Thursday Jan 28, 2021
Thursday Jan 28, 2021
This episode is shared from Answers from the Lab and was originally published January 28, 2021.
Guest: William G. Morice, II M.D., Ph.D. (@moricemdphd)
Host: Bobbi S. Pritt, M.D. (@ParasiteGal)
William Morice II, M.D., Ph.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and president of Mayo Clinic Laboratories, joins the "Answers From the Lab" podcast for his weekly leadership update. In this episode, Dr. Morice and Bobbi Pritt, M.D., discuss the new nationwide strategy that the Biden administration is rolling out to combat COVID-19.
For more, follow the Mayo Clinic Labs on Twitter @mayocliniclabs or visit https://news.mayocliniclabs.com/podcast/answers-from-the-lab/ to check out all of their episodes.
Tuesday Jan 26, 2021
Tuesday Jan 26, 2021
Guest: Eric J. Cleveland; Danielle M. Teal (@dteal)
Host: Amit K. Ghosh, M.D. (@AmitGhosh006)
Joy has been defined as a human emotion — a state created as we experience positive, poignant, reflective and connective moments. It is transient, never persisting but imparting ripples that impact us long after the moment.
Now more than ever there is a need to develop mindful initiatives that brings joy in our personal lives and in the workplace. In this episode we speak with Eric Cleveland and Danielle Teal, two leaders of the Joy at Mayo Clinic (J@M) initiative. We will discuss the joy equation, the Institute of Health Improvement’s (IHI) Framework for Improving Joy in Work and discuss examples of pragmatic initiatives that can bring joy at both the individual and team levels.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.
Thursday Jan 21, 2021
Thursday Jan 21, 2021
This episode is shared from Mayo Clinic Q&A and was recorded on January 11, 2021.
To claim credit visit: https://ce.mayo.edu/covid19podcast
Guest: Gregory A. Poland, M.D. (@drgregpoland)
Host: Halena M. Gazelka, M.D. (@hmgazelkamd)
The U.S. rollout of COVID-19 vaccines is reportedly ramping up with news that nearly all available doses will soon be released to the American public.
"The new COVID-19 variants are traveling quickly, and this is a warning that we need to take precautions," says Dr. Gregory Poland, an infectious diseases expert and head of Mayo Clinic's Vaccine Research Group.
Dr. Poland says these new variants are a consequence of an RNA virus being transmitted from human to human. "Even after we get our vaccines, we still need to wear masks out in public. We still need to maintain physical distancing. And we still need to wash our hands until about 80% of people get their COVID-19 vaccines," Dr. Poland emphasizes.In this Mayo Clinic Q&A podcast, Dr. Poland goes into detail about the COVID-19 vaccines, including "sterilizing immunity," testing for antibodies after receiving the vaccine, the possibility of booster doses in the future and much more.
AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.
Tuesday Jan 19, 2021
Tuesday Jan 19, 2021
Guest: Leslie A. Sim, Ph.D., L.P. (@DrLeslieSim)
Host: Darryl S. Chutka, M.D. (@ChutkaMD)
A variety of eating disorders can occur in adults and they are associated with multiple potential health complications, including an increased risk of death. Some studies report that up to 20% of those with Anorexia Nervosa will die as a result of the condition. Would you recognize an eating disorder in the patients you see? What clues should you look for? In this week’s Mayo Clinic Talks, we’ll speak with Dr. Leslie Sim, a psychologist at the Mayo Clinic. We’ll discuss who is most likely to develop an eating disorder, important “red flag” symptoms, questions you should ask patients to help confirm a diagnosis, and how we should approach a patient we suspect has an eating disorder.
Topics discussed:
- Definition of an eating disorder
- Important “red flag” symptoms that may indicate an eating disorder
- Health complications that can occur as a result of an eating disorder
- Who is most likely to have an eating disorder
- The genetic component to eating disorders
- Clues from their childhood that suggest patients may have an eating disorder as an adult
- Events which can trigger an eating disorder
- When we should suspect an eating disorder
- How we should approach a patient we suspect has an eating disorder
- Management of eating disorders
- Effectiveness of treatment
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.
Thursday Jan 14, 2021
Thursday Jan 14, 2021
This episode is shared from Mayo Clinic Q&A and was recorded in January, 2021.
Guests: Emily R. Levy, M.D. (@EmilyLevy797); Nipunie S. Rajapakse, M.D., M.P.H. (@nrajapakseMD)
Host: Angela C. Mattke, M.D. (@DrAngelaMattke)
Around the world, COVID-19 vaccinations are underway, but only in adults. Pfizer's vaccine has been authorized for ages 16 and up, while Moderna's vaccine is currently authorized for ages 18 and up. Vaccines are generally tested in adults first to ensure they are safe for pediatric trials. Both Pfizer and Moderna now have clinical trials underway to study the safety and effectiveness of COVID-19 vaccines in children.
This edition of the Mayo Clinic Q&A podcast features an #AskMayoMom episode hosted by Dr. Angela Mattke, a pediatrician at Mayo Clinic Children's Center. Joining Dr. Mattke to discuss COVID-19, vaccines and children are Dr. Nipunie Rajapakse, a Mayo Clinic pediatric infectious diseases physician, and Dr. Emily Levy, a Mayo Clinic pediatric critical care and infectious diseases expert. Dr. Levy also discusses multisystem inflammatory syndrome in children, also known as MIS-C.
AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.
Tuesday Jan 12, 2021
Tuesday Jan 12, 2021
Guest: Corey M. Kunzer, P.T., D.P.T., SCS, (@KunzerCorey) and Edward R. Laskowski, M.D. (@DrEdSportsMed)
Host: Darryl S. Chutka, M.D. (@ChutkaMD)
Over the past decade more individuals have begun working remotely; the numbers have increased dramatically this past year with the COVID-19 pandemic. While there are some advantages to working remotely, there are also some potential problems associated with it. Those working from home often develop a variety of musculoskeletal problems including low back and neck pain, as well as shoulder and extremity discomfort. Drs. Edward Laskowski, a physician and Corey Kunzer, a physical therapist, both in the Department of Physical Medicine and Rehabilitation at the Mayo Clinic will discuss some of the musculoskeletal problems associated with working remotely.
Specific topics discussed:
- Frequency of musculoskeletal problems associated with working from home
- Differences between working at home vs. the traditional office
- Issues to consider when selecting a desk and chair
- Recommended positions of the monitor, keyboard and mouse
- Benefits of a standing workstation or working while walking on a treadmill
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.
Tuesday Jan 05, 2021
Tuesday Jan 05, 2021
Guest: Andrew Jagim, Ph.D. (@AJagim)
Host: Darryl S. Chutka, M.D. (@ChutkaMD)
Billions of dollars per year are spent in the U.S. on nutritional supplements to enhance performance. Multiple nutritional supplements are commercially available and are marketed for enhancing endurance, building muscle strength, improving exercise efficiency, and decreasing the potential for injury. Do these supplements actually deliver the benefits they claim? Are they safe? What age athletes are taking these supplements? We’ll discuss these topics and more with Dr. Andrew Jagim, the director of sports medicine research at the Mayo Clinic.
Specific topics:
- Recommended approach to the athlete who wants to improve their performance
- Potential benefits of nutritional supplements for athlete's
- Age of athletes taking nutritional supplements
- Selecting a high-quality nutritional supplement
- Reliable web sites reviewing the available nutritional supplements including potential benefits and safety
- Review of commonly taken nutritional supplements
- Nutritional supplements which have potential harm
Additional Resources:
- Mayo Clinic Proceedings Article: https://www.mayoclinicproceedings.org/article/S0025-6196(20)30363-3/fulltext
- NIH – Office of Dietary Supplements: https://ods.od.nih.gov/factsheets/ExerciseAndAthleticPerformance-HealthProfessional/
- International Society of Sports Nutrition (ISSN): https://www.sportsnutritionsociety.org/
- Third-Party Testing Information: https://examine.com/
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.
Monday Jan 04, 2021
Monday Jan 04, 2021
This episode is shared from Mayo Clinic Q&A and was recorded in December, 2020.
Guest: Tyler Oesterle, M.D., M.P.H. (@OesterleMD)
Host: Halena M. Gazelka, M.D. (@hmgazelkamd)
Stress, isolation and limited access to resources are fueling rising rates of substance abuse and overdoses during the COVID-19 pandemic. While coronavirus has been the focus of so much attention this year, the opioid crisis has continued unabated and has even worsened. More than 40 states have reported increases in opioid related deaths, according to the American Medical Association.
On the Mayo Clinic Q&A podcast, Dr. Tyler Oesterle, a psychiatrist and addiction expert at Mayo Clinic, discusses opioid use disorders and treatment options, including virtual medicine available during the pandemic.
AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.
Friday Jan 01, 2021
Friday Jan 01, 2021
This episode is shared from Mayo Clinic Q&A and was recorded in December, 2020.
Guest: John (Jack) C. O'Horo, M.D., M.P.H. (@jcohoro)
Host: Halena M. Gazelka, M.D. (@hmgazelkamd)
A recent Mayo Clinic study published in Mayo Clinic Proceedingsfound that patients with COVID-19 who received care at Mayo Clinic had lower mortality rates than the national average. Mayo Clinic patients were treated using an integrated, team-based approach for patient monitoring and treatment.
On the Mayo Clinic Q&A podcast, Dr. John O'Horo, a Mayo Clinic infectious diseases physician and the study's first author, discusses the study results and explains how the Mayo Clinic Model of Care improves outcomes for patients.
AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.
Tuesday Dec 29, 2020
Tuesday Dec 29, 2020
Guest: Alisha Morgan, D.O. (@AAMORGAN_DO)
Host: Darryl S. Chutka, M.D. (@ChutkaMD)
It’s estimated that there may be over 30 million individuals in the U.S. who provide ongoing care to older adults, half of these to family members with some form of dementia. The majority of these caregivers are female and a significant percentage of these caregivers have their own major health problems. This has become a major social and economic issue in the care of our geriatric patients. Dr. Alisha Morgan, a family medicine and hospice physician at the Mayo Clinic joins us to address the challenges associated with being a caregiver, how healthcare providers should assess caregiver burden, potential financial resources available to assist caregivers, and interventions to reduce the impact of stress on caregivers.
Specific topics:
- Morbidity and mortality of care givers
- The amount of time caregivers devote to assisting older adults
- Financial burden of providing chronic care to older adults
- How primary care providers should acknowledge caregivers
- How primary care providers should evaluate
- How caregiver stress should be provided
- Available financial resources for caregivers
Caregiver Resources: https://www.aarp.org/content/dam/aarp/entertainment/books/2015-04/Caregivers_Excerpt.pdf
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.
Monday Dec 21, 2020
Monday Dec 21, 2020
This episode was recorded on December 18, 2020.
To claim credit visit: https://ce.mayo.edu/covid19podcast
Guest: Gregory A. Poland, M.D. (@drgregpoland)
Host: Amit K. Ghosh, M.D., M.B.A. (@AmitGhosh006)
It is projected that by March of 2021 1:700 Americans will have died of COVID-19. The historic pace of COVID-19 vaccine development was made possible by the countless sacrifices of many individuals across healthcare, research, health and human services, the Department of Defense, and other key sectors. This interprofessional collaboration required many to set life aside and work tirelessly to bring an effective vaccine to market, quickly. While mRNA vaccines have been in development since the 1990s, the COVID-19 vaccine efficacy rate of 95-100% across studied ages, race and ethnicities, and comorbidities is unprecedented. The questions left to answer are, how long will the efficacy last? In larger population studies, what is the safety/allergy/hypersensitivity profile? What impact does the vaccine have on asymptomatic carrier spread? Who shouldn’t get the vaccine? Dr. Greg Poland breaks down everything you need to know about the mRNA COVID-19 vaccines.
Additional Resources:
- Mayo Clinic Vaccine Research Page
https://www.mayo.edu/research/labs/vaccine-research-group/overview - Vaccine education spectrum disorder: the importance of incorporating psychological and cognitive models into vaccine education
- https://www.sciencedirect.com/science/article/pii/S0264410X11011881
- AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.